A Phase II, Single-Center, Randomized, Double-Blind, Assessment of the Abuse Liability of Acurox (oxycodone HCl and niacin) Tablets in Subjects with a History of Opioid Abuse
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2018
At a glance
- Drugs Oxycodone (Primary) ; Niacin; Oxycodone/niacin
- Indications Drug abuse; Pain
- Focus Therapeutic Use
- Sponsors Acura Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 22 Oct 2008 Status changed from planning to completed, as reported by clinicaltrials.gov.
- 13 Oct 2008 Top-line results have been reported by Acura Pharmaceuticals in a media release.